Talk:Pegvisomant

Wiki Education Foundation-supported course assignment

This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): KFunk740.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 06:19, 17 January 2022 (UTC)

In the News

This drug is the subject of a current event: http://www.nytimes.com/2011/02/17/science/17longevity.html —Preceding unsigned comment added by 148.87.67.132 (talk) 01:55, 17 February 2011 (UTC)

Origin

John Kopchick discovered Pegvisomant in 1987, and it was approved by the FDA in 2003. This information should be included in this article. Here's an interesting source for that: http://www.ohio.edu/research/communications/royaltymonetization.cfm

 --Dulcimerist (talk) 21:05, 6 May 2012 (UTC)

Side Effects

Citations relatively outdated, and incomplete/inaccurate. See more extensive data in Acrostudy KFunk740 (talk) 15:36, 19 October 2016 (UTC)

References

Other Uses

Pegvisomant can potentially inhibit growth of some types of tumors., KFunk740 (talk) 15:46, 19 October 2016 (UTC)

References

General Comments

Overall structure is OK enough, but can be expanded quite a bit. I agree with Dulcimerist, that article needs a section on the drug discovery and linked to John Kopchick's wiki article, along with revenue data for Ohio University. Intro section needs to be clarified. It appears imbalanced toward lack of efficacy, but more recent data is more convincing that it does improve health and quality of life. Sources stated aren't reliable enough. (hopefully this gets a few more points on assignment). KFunk740 (talk) 00:14, 28 October 2016 (UTC)